BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 33240524)

  • 1. Functional characterisation guides classification of novel
    Hong JH; Chong ST; Lee PH; Tan J; Heng HL; Ishak NDB; Chan SH; Teh BT; Ngeow J
    NPJ Genom Med; 2020; 5():50. PubMed ID: 33240524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sensitivity to asbestos is increased in patients with mesothelioma and pathogenic germline variants in BAP1 or other DNA repair genes.
    Betti M; Aspesi A; Ferrante D; Sculco M; Righi L; Mirabelli D; Napoli F; Rondón-Lagos M; Casalone E; Vignolo Lutati F; Ogliara P; Bironzo P; Gironi CL; Savoia P; Maffè A; Ungari S; Grosso F; Libener R; Boldorini R; Valiante M; Pasini B; Matullo G; Scagliotti G; Magnani C; Dianzani I
    Genes Chromosomes Cancer; 2018 Nov; 57(11):573-583. PubMed ID: 30338612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toward automation of germline variant curation in clinical cancer genetics.
    Ravichandran V; Shameer Z; Kemel Y; Walsh M; Cadoo K; Lipkin S; Mandelker D; Zhang L; Stadler Z; Robson M; Offit K; Vijai J
    Genet Med; 2019 Sep; 21(9):2116-2125. PubMed ID: 30787465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concurrent germline and somatic pathogenic BAP1 variants in a patient with metastatic bladder cancer.
    Tesch ME; Pater JA; Vandekerkhove G; Wang G; Binnington K; So AI; Wyatt AW; Eigl BJ
    NPJ Genom Med; 2020; 5():12. PubMed ID: 32218990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Population-based analysis of BAP1 germline variations in patients with uveal melanoma.
    Repo P; Järvinen RS; Jäntti JE; Markkinen S; Täll M; Raivio V; Turunen JA; Kivelä TT
    Hum Mol Genet; 2019 Jul; 28(14):2415-2426. PubMed ID: 31058963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BAP1 Germline Mutations in Finnish Patients with Uveal Melanoma.
    Turunen JA; Markkinen S; Wilska R; Saarinen S; Raivio V; Täll M; Lehesjoki AE; Kivelä TT
    Ophthalmology; 2016 May; 123(5):1112-7. PubMed ID: 26876698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and Preliminary Validation of Screening Criteria to Identify Carriers of Germline BAP1 Mutations.
    Zauderer MG; Jayakumaran G; DuBoff M; Zhang L; Francis JH; Abramson DH; Cercek A; Nash GM; Shoushtari A; Chapman P; D'Angelo S; Arnold AG; Siegel B; Fleischut MH; Ni A; Rimner A; Rusch VW; Adusumilli PS; Travis W; Sauter JL; Zehir A; Mandelker D; Ladanyi M; Robson M
    J Thorac Oncol; 2019 Nov; 14(11):1989-1994. PubMed ID: 31323388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Germline versus Somatic BAP1 Mutations for Risk of Metastasis in Uveal Melanoma.
    Ewens KG; Lalonde E; Richards-Yutz J; Shields CL; Ganguly A
    BMC Cancer; 2018 Nov; 18(1):1172. PubMed ID: 30477459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BAP1 germline mutation in two first grade family members with uveal melanoma.
    Maerker DA; Zeschnigk M; Nelles J; Lohmann DR; Worm K; Bosserhoff AK; Krupar R; Jägle H
    Br J Ophthalmol; 2014 Feb; 98(2):224-7. PubMed ID: 24187051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mesothelioma developing in carriers of inherited genetic mutations.
    Yoshikawa Y; Emi M; Nakano T; Gaudino G
    Transl Lung Cancer Res; 2020 Feb; 9(Suppl 1):S67-S76. PubMed ID: 32206572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumours associated with BAP1 mutations.
    Murali R; Wiesner T; Scolyer RA
    Pathology; 2013 Feb; 45(2):116-26. PubMed ID: 23277170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Characteristics of Uveal Melanoma in Patients With Germline BAP1 Mutations.
    Gupta MP; Lane AM; DeAngelis MM; Mayne K; Crabtree M; Gragoudas ES; Kim IK
    JAMA Ophthalmol; 2015 Aug; 133(8):881-7. PubMed ID: 25974357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of BAP1 Germline Gene Mutation in Young Uveal Melanoma Patients.
    Cebulla CM; Binkley EM; Pilarski R; Massengill JB; Rai K; Liebner DA; Marino MJ; Singh AD; Abdel-Rahman MH
    Ophthalmic Genet; 2015 Jun; 36(2):126-31. PubMed ID: 25687217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Puzzling Results from
    Rizzardi C; Athanasakis E; Cammisuli F; Monego SD; DE Spelorzi YCC; Costantinides F; Giudici F; Pinamonti M; Canzonieri V; Melato M; Pascolo L
    Anticancer Res; 2017 Jun; 37(6):3073-3083. PubMed ID: 28551647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive review of BAP1 tumor predisposition syndrome with report of two new cases.
    Rai K; Pilarski R; Cebulla CM; Abdel-Rahman MH
    Clin Genet; 2016 Mar; 89(3):285-94. PubMed ID: 26096145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Subset of Mesotheliomas With Improved Survival Occurring in Carriers of BAP1 and Other Germline Mutations.
    Pastorino S; Yoshikawa Y; Pass HI; Emi M; Nasu M; Pagano I; Takinishi Y; Yamamoto R; Minaai M; Hashimoto-Tamaoki T; Ohmuraya M; Goto K; Goparaju C; Sarin KY; Tanji M; Bononi A; Napolitano A; Gaudino G; Hesdorffer M; Yang H; Carbone M
    J Clin Oncol; 2018 Oct; 36(35):JCO2018790352. PubMed ID: 30376426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of ACMG criteria to classify variants in the human gene mutation database.
    Qu HQ; Wang X; Tian L; Hakonarson H
    J Hum Genet; 2019 Nov; 64(11):1091-1095. PubMed ID: 31451714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel BAP1 mutation is associated with melanocytic neoplasms and thyroid cancer.
    McDonnell KJ; Gallanis GT; Heller KA; Melas M; Idos GE; Culver JO; Martin SE; Peng DH; Gruber SB
    Cancer Genet; 2016 Mar; 209(3):75-81. PubMed ID: 26774355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histomorphologic spectrum of germline-related and sporadic BAP1-inactivated melanocytic tumors.
    Garfield EM; Walton KE; Quan VL; VandenBoom T; Zhang B; Kong BY; Isales MC; Panah E; Kim G; Gerami P
    J Am Acad Dermatol; 2018 Sep; 79(3):525-534. PubMed ID: 29753057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrating somatic variant data and biomarkers for germline variant classification in cancer predisposition genes.
    Walsh MF; Ritter DI; Kesserwan C; Sonkin D; Chakravarty D; Chao E; Ghosh R; Kemel Y; Wu G; Lee K; Kulkarni S; Hedges D; Mandelker D; Ceyhan-Birsoy O; Luo M; Drazer M; Zhang L; Offit K; Plon SE
    Hum Mutat; 2018 Nov; 39(11):1542-1552. PubMed ID: 30311369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.